|
Á¦À̾¾¹ÙÀÌ¿ÀÆĸ¶ |
Á¦¾àº´¿ø¿µ¾÷ °æ·ÂÁ÷ »ç¿ø ¸ðÁý
Àü±¹ Àü±¹ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
ä¿ë½Ã |
12.06 |
|
|
½´¹ÌÆ®ÇコÄÚ¸®¾ÆÀ¯ÇÑȸ»ç |
½´¹ÌÆ®ÇコÄÚ¸®¾Æ ¼öÀÔ°ü¸®¾à»ç ä¿ë°ø°í
°æ±â Çϳ²½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
10.19 |
|
|
(ÁÖ)¼Æ펾àÇ° |
ÀǾàÇ°¼öÀÔ, ¾ÈÀü°ü¸®/Çã°¡ ¾à»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.28 |
|
|
[KOTRA]CRISTALIA |
[KOTRA] ºê¶óÁú, Cristália Produtos Farmacêu
ÇØ¿Ü ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
°æ·Â¹«°ü |
ä¿ë½Ã |
08.20 |
|
|
(ÁÖ)½ºÆä¼È³ëºí·¹½º±×·ì |
ÅÍÅ° ÁöÁßÇØÈÞ¾çÁö ¾ÈÅ»¸®¾Æ ¸ÅÀå ±Ù¹« Á÷¿øºÐÀ» ¸ð½Ê´Ï´Ù.
ÇØ¿Ü À¯·´ | Çз¹«°ü |
°Ç°º¸Á¶½ÄÇ°/ÈÀåÇ°¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
07.27 |
|
|
ÇùÁø¹«¾à |
¼öÀÔ°ü¸®¾à»ç/¾à»ç ¹× ÇѾà»ç ´ã´çÀÚ Ã¤¿ë
¼¿ï °ü¾Ç±¸ | Çз¹«°ü |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
07.04 |
|
|
¸ÞµðÄɾîÆÊ |
±ä±Þ¸ðÁý/ÀÇ·á¼Ò¸ðÇ°+ÀǾ൵¸Å+°£È£½Ç½À¹°Ç° ³³Ç°¿µ¾÷ °æ·Â
°æ±â ºÎõ½Ã ¿ø¹Ì±¸, °æ±â ºÎõ½Ã ¿ÀÁ¤±¸, °æ±â ºÎõ½Ã ¼Ò»ç±¸ | Çз¹«°ü |
¹è¼Û/³³Ç°/¿îÀü±â»ç |
3³â¡è |
ä¿ë½Ã |
06.22 |
|
|
Veeva Systems Korea YH |
Solution Consultant - Vault R&D
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
04.24 |
|
|
Veeva Systems Korea YH |
Account Executive - R&D Vault
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
04.24 |
|
|
Veeva Systems Korea YH |
CRM Consultant
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
04.24 |
|
|
Veeva Systems Korea YH |
Senior Consultant - R&D Vault
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
04.24 |
|
|
Àϻ꺹À½ÀçÈ°¿ä¾çº´¿ø |
Àϻ꺹À½ÀçÈ°¿ä¾çº´¿ø ¾à»ç ä¿ë°ø°í
°æ±â °í¾ç½Ã Àϻ걸 | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
04.18 |
|
|
(ÁÖ)ÀϽŹÙÀÌ¿Àºê·£Ä¡ |
ÀÌÈÇбâ±â °ü·Ã ¿µ¾÷ »ç¿ø ¸ðÁý
¼¿ï Á߶û±¸ | °íµîÇб³ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.13 |
|
|
(ÁÖ)ÆÒÁ¨ |
ÀÇ»ç, ¾à»ç ¶Ç´Â ÇѾà»ç´ÔÀ» ¸ð½Ê´Ï´Ù.
°æ±â ¼ö¿ø½Ã ¿µÅ뱸 | Çз¹«°ü |
˂ȍ |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.02 |
|
|
(ÁÖ)¾Ë¹ÙÀÌ¿À |
¿¹¼ºÀÇ·áÀç´Ü ¾ç»êº£µ¥½º´Ù º´¿ø ±¸¸Å°ü¸® °æ·ÂÁ÷(ÆÀÀå) ä
°æ³² ¾ç»ê½Ã | ´ëÇÐ(2~3³â) Á¹¾÷ |
»ý»êÁö¿ø/¹°·ù/±¸¸Å |
10³â¡è |
ä¿ë½Ã |
02.20 |
|